Reuters, May 13 – On Friday, Moderna Inc (MRNA.O) said that Swissmedic has approved the use of its COVID-19 vaccination for children aged 6 to 11.

Moderna explained that the approval is for the vaccine’s two-dose series of 50 microgram each dose.

[embedpost slug=”moderna-seeks-us-authorization-for-covid-vaccine-in-children-under-6/”]